The artificial intelligence (AI)-powered Ezra Flash reportedly enhances magnetic resonance imaging (MRI) and enables significant reductions in scan times and costs for full-body MRI.
Could 30-minute full-body magnetic resonance imaging (MRI) exams be a reality in the near future?
The Food and Drug Administration (FDA) has granted 510(k) clearance for Ezra Flash (Ezra), an artificial intelligence-enabled software that enhances the quality of images derived from a fast MRI protocol, according to Ezra, the developer of the software.
Emphasizing that Ezra Flash was trained on hundreds of thousands of MRI scans from a proprietary dataset, Ezra said the technology facilitates simultaneous image quality and scan time reduction to the point where it can reduce the costs of full-body MRI by 30 percent.
Noting that Ezra Flash has received FDA clearance for brain imaging, the company plans to utilize the technology to launch the first 30-minute full-body MRI.
Possibly facilitating proactive cancer detection for a broader patient base beyond those with established risk factors, the FDA clearance of Ezra Flash may represent the “ … beginning of a sea change in how medical imaging is used,” noted Daniel K. Sodickson, M.D., Ph.D., the chief of innovation and director of the Center for Advanced Imaging Innovation and research in the Department of Radiology at New York University (NYU).
“Ezra Flash will increase the accessibility of early-warning MRI, and Ezra’s dataset of repeated scans over time will help it to prevent false positives and ensure that the warnings it provides are appropriate and accurate,” emphasized Dr. Sodickson.
(Editor’s note: For related content, see “Can Alternative MRI Techniques Help Enhance CyberKnife Treatment Imaging?”)
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.